BIOABioAge Labs, Inc.
$5.09-0.39% 1Y
$5.09
$4.8352 weeks$25.12
Is the price fair?
What BIOA's price assumes
BioAge Labs, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 106× revenue.
106
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.93
Price / book · as of 2026-Q2
- EV / sales
- 75.3
EV / sales
Details›
- Price / bookas of 2026-Q2
- 2.93
- EV / EBIToperating margin −1026%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 75.3
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Stocks with no debt
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry